-
McLelland GL, Lopez-Osias M, Verzijl CRC, et al. Identification of an alternative triglyceride biosynthesis pathway. Nature. 2023; 621(7977):171-178 doi.org/10.1038/s41586-023-06497-4
-
Gulen MF, Samson N, Keller A, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature. 2023; 620(7973):374-380 doi.org/10.1038/s41586-023-06373-1
-
Morgner J, Bornes L, Hahn K, et al. A Lamb1Dendra2 mouse model identifies basement-membrane-producing origins and dynamics in PyMT breast tumors. Dev Cell. 2023;58(7):535-549 doi.org/10.1016/j.devcel.2023.02.017
Service Description:
The Animal Modelling Facility (AMF) at the Netherlands Cancer Institute (NKI) provides all services related to the generation of genetically engineered mice (GEM) based on zygote manipulation by CRISPR/Cas9 procedures, including full-service covering the design and all hands-on steps. The AMF keeps track of recent technological developments and tests their usefulness for improving model generation. These include the application of CRISPR/Cas technologies in combination with Adeno Associated Viral vectors for the targeted introduction of larger inserts up to 4kbp.